CIN (cervical intra-epithelial neoplasia) is usually the result of a virus infection: the human papilloma virus (HPV). HPV is a very common virus that can affect the cells of the cervix. It is mainly passed on during sexual intercourse. Most women who have had sexual intercourse will have the virus at some time in their life, but for many their immune system will get rid of the virus and they won't even know they had it.
Cancer of the cervix can take many years to develop. Before it does, early changes occur in the cells of the cervix. These abnormal cells are not cancerous, and are called (CIN). Some doctors call these changes pre-cancerous. This means that the cells might develop into cancer if they are not treated. It is important to know that most women with CIN do not develop cancer. CIN may also be referred to as dysplasia or dsykaryosis.
Most women have regular cervical screening (the smear test). The test is designed to find early changes in the cells of the cervix, so that treatment can be given to prevent a cancer from developing. Although the aim of cervical screening is to prevent cancer, it can also sometimes detect a cancer that has already developed.
There are more than 100 types of HPV and each type is identified by a number (e.g. HPV 16). Some types of the virus can cause genital warts, and other types can cause CIN in the cells of the cervix. The CIN usually clears up once the immune system has got rid of the virus. In some women the virus remains for a number of years and in a few of these women the CIN will develop into cancer if it is not treated.
The type of HPV can affect whether CIN develops or not - only certain types, such as 16, 18, 31 and 33 (known as 'high risk' types) seem to be associated with the development of abnormalities of the cervix.
Many women have heard that having sexual intercourse at an early age and having multiple sexual partners can increase the risk of developing cervical cancer. They may be distressed that friends and family could think they fall into these categories.
It is important to remember that although these factors can increase the chances of catching the virus, many women who have only had one sexual partner have HPV, and may go on to develop CIN or cervical cancer. So there is no reason for yourself or others to feel that you are to blame for having cervical cancer.
You have heard about the new quadrivalent vaccine against human papilloma virus (HPV) GARDASIL which will both prevent cervical carcinoma (approximately 200 women a year die from this condition in the UK ) (HPV16/8) and reduce this incidence of genital warts by 90%.(HPV 6/11) in the vaccinated population.
It now has a product license in the UK for children between the ages of 9-26 years (girls ) and 9-16(boys).
My wholehearted recommendation is that boys and girls should receive it when they attain the age of 9. (The boys should receive it both to reduce the risk of genital warts and to reduce the population carriage of HPV 16 and 18 which can cause cervical carcinoma in women.) Protection against the papilloma viruses is likely to be long lasting.
The immunisation programme is for 3 doses of the vaccine:
First dose Time 0
Second dose 2 months
Third dose 6 months